Senior Vice President, Clinical Operations Early Phase Worldwide Clinical Trials
Session Description
Join this engaging and interactive session exploring the critical balance between Normal Healthy Volunteers (NHVs) and Patient participants in clinical trials. This session aims to highlight the often-underrepresented role of NHVs, who are pivotal in establishing the safety profile of investigational treatments before they reach patient populations.
To foster dynamic discussion, the room will be divided into two groups: one representing the perspective of NHVs in Phase 1 trials and the other representing Patients in later-phase studies. Each group will address key questions, offering insights into their unique contributions, challenges, and considerations in clinical research. By bringing NHVs back into the conversation, this session underscores their essential role while exploring how to optimize participant selection for safe and effective clinical trials.
Brought to you by:
This event is sponsored by an ASCPT Partner organization. ASCPT partners were not involved in the development or content of this program.
